Exacerbations of chronic obstructive pulmonary disease and quality of life of patients

Advances in Experimental Medicine and Biology

Volumn 884, Issue , 2016, Pages 69-74

  Rubinsztajn, R ^a   Przybylowski T ^a   Maskey Warzechowska M ^a   Karwat, K ^a   Chazan, R ^a  

^a MEDICAL UNIVERSITY OF WARSAW   (Poland)

Author keywords

Chronic obstructive pulmonary disease; Dyspnea; Exacerbation; GOLD staging; Quality of life; Spirometry; St. George s Respiratory Questionnaire

Indexed keywords

ADULT; AGED; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; DISEASE CLASSIFICATION; DISEASE EXACERBATION; DISEASE SEVERITY; DYSPNEA; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; QUALITY OF LIFE; RISK ASSESSMENT; SEX DIFFERENCE; SPIROMETRY; COST OF ILLNESS; DISEASE COURSE; LUNG; MIDDLE AGED; PATHOPHYSIOLOGY; PROGNOSIS; PSYCHOLOGY; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; QUESTIONNAIRE; RISK FACTOR; SEVERITY OF ILLNESS INDEX; TIME FACTOR; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; COST OF ILLNESS; DISEASE PROGRESSION; FEMALE; HUMANS; LUNG; MALE; MIDDLE AGED; PROGNOSIS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; QUALITY OF LIFE; RISK FACTORS; SEVERITY OF ILLNESS INDEX; SPIROMETRY; SURVEYS AND QUESTIONNAIRES; TIME FACTORS;

EID: 84949575557     PISSN: 00652598     EISSN: 22148019     Source Type: Book Series    
DOI: 10.1007/5584_2015_178     Document Type: Chapter

References (30)

1. Alonso J, Ferrer M, Gandek B, Ware JE Jr, Aaronson NK, Mosconi P, Rasmussen NK, Bullinger M, Fukuhara S, Kaasa S, Leple`ge A, IQOLA Project Group (2004) Health-related quality of life associated with chronic conditions in eight countries: results from the International Quality of Life Assessment (IQOLA) Project. Qual Life Res 13:283–298
2. Antonelli-Incalzi R, Imperiale C, Bellia V, Catalano F, Scichilone N, Pistelli R, Rengo F, SaRA Investigators (2003) Do GOLD stages of COPD severity really correspond to differences in health status? Eur Respir J 22:444–449
3. Black-Shinn JL, Kinney GL, Wise AL, Regan EA, Make B, Krantz MJ, Barr RG, Murphy JR, Lynch D, Silverman EK, Crapo JD, Hokanson JE, COPD Gene Investigators (2014) Cardiovascular disease is associated with COPD severity and reduced functional status and quality of life. COPD 11:546–551
4. Burge S, Wedzicha JA (2003) COPD exacerbations: definitions and classifications. Eur Respir J 41:46s–53s
5. Burgel PR, Escamilla R, Perez T, Carre P, Caillaud D, Chanez P, Pinet C, Jebrak G, Brinchault G, Court-Fortune I, Paillasseur JL, Roche N (2013) Impact of comorbidities on COPD-specific health-related quality of life. Respir Med 107:233–241
6. Donaldson GC, Seemungal TA, Bhowmik A, Wedzicha JA (2002) Relationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary disease. Thorax 57:847–852
7. Esteban C, Quintana JM, Moraza J, Aburto M, Egurrola M, Espana PP, Pérez-Izquierdo J, Aguirre U, Aizpiri S, Capelastegui A (2009) Impact of hospitalisations for exacerbations of COPDon health-related quality of life. Respir Med 103:1201–1208
8. GOLD (2010) Global Initiative for Chronic Obstructive Lung Disease. Global strategy for diagnosis, management, and prevention of COPD. http://www.goldcopd.org. Updated 2010. Accessed on 11 Apr 2011
9. GOLD (2014) Global Initiative for Chronic Obstructive Lung Disease. Global strategy for diagnosis, management, and prevention of COPD. http://www.gold. copd.org. Accessed on 20 Nov 2013
10. Halpin DM, Decramer M, Celli B, Kesten S, Liu D, Tashkin DP (2012) Exacerbation frequency and course of COPD. Int J Chron Obstruct Pulmon Dis 7:653–661
11. Hoogendoorn M, Feenstra TL, Hoogenveen RT, Al M, Molken MR (2010) Association between lung function and exacerbation frequency in patients with COPD. Int J COPD 5:435–444
12. Iguchi A, Senjyu H, Hayashi Y, Kanada R, Iwai S, Honda S, Kitagawa C, Ozawa H, Rikitomi N (2013) Realtionship between depression in patients with COPD and the percent of predicted FEV1, BODE Index and health-related quality of life. Respir Care 58:334–339
13. Jenkins CR, Celli B, Anderson JA, Ferguson GT, Jones PW, Vestbo J, Yates JC, Calverley PM (2012) Seasonality and determinants of moderate and severe COPD exacerbations in the TORCH study. Eur Respir J 39:38–45
14. Jones PW, Quirk FH, Baveystock CM (1991) The St. George’s Respiratory Questionnaire. Respir Med 85(Suppl B):25–31
15. Jones PW, Brusselle G, Dal Negro RW, Ferrer M, Kardos P, Levy ML, Perez T, Soler-Cataluňa JJ, van der Molen T, Adamek L, Banik N (2011) Healthrelated quality of life in patients by COPD severity within primary care in Europe. Respir Med 105:57–66
16. Kanner RE, Anthonisen NR, Connett JE (2001) Lower respiratory illnesses promote FEV1 decline in current smokers but not ex-smokers with mild chronic obstructive pulmonary disease: results from the lung health study. Am J Respir Crit Care Med 164:358–364
17. Laurin C, Moullec G, Bacon SL, Lavoie KL (2012) Impact of anxiety and depression on chronic obstructive pulmonary disease exacerbation risk. Am J Respir Crit Care Med 185:918–923
18. Llor C, Molina J, Naberan K, Cots JM, Ros F, Miravitlles M (2008) Exacerbations worsen the quality of life of chronic obstructive pulmonary disease patients in primary healthcare. Int J Clin Pract 62:585–592
19. Mahler DA, Wells CK (1988) Evaluation of clinical methods for rating dyspnea. Chest 93:580–586
20. Medinas Amoros M, Mas-Tous C, Renom-Sotorra F, Rubi-Ponseti M, Centeno-Flores MJ, Gorriz-Dolz MT (2009) Health-related quality of life is associated with COPD severity: a comparison between the GOLD staging and the BODE index. Chron Respir Dis 6:75–80
21. Miravitlles M, Ferrer M, Pont A, Zalacain R, Alvarez-Sala JL, Masa F, Verea H, Murio C, Ros F, Vidal R (2004) Effect of exacerbations on quality of life in patients with chronic obstructive pulmonary disease: a 2 year follow up study. Thorax 59:387–395
22. Müllerová H, Shukla A, Hawkins A, Quint J (2014) Risk factors for acute exacerbations of COPD in a primary care population: a retrospective observational cohort study. Br Med J Open 4:e006171
23. Seemungal TA, Donaldson GC, Paul EA, Bestall JC, Jeffries DJ, Wedzicha JA (1998) Effect of exacerbation on quality of life in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 157:1418–1422
24. Seemungal TA, Donaldson GC, Bhowmik A, Jeffries DJ, Wedzicha JA (2000) Time course and recovery of exacerbations in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 161:1608–1613
25. Singanayagam A, Schembri S, Chalmers JD (2013) Predictors of mortality in hospitalized adults with acute exacerbation of chronic obstructive pulmonary disease. Ann Am Thorac Soc 10:81–89
26. Solem CT, Sun SX, Sudharshan L, Macahilig C, Katyal M, Gao X (2013) Exacerbation-related impairment of quality of life and work productivity in severe and very severe chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis 8:641–652
27. Suissa S, Dell’Aniello S, Ernst P (2012) Long-term natural history of chronic obstructive pulmonary disease: severe exacerbations and mortality. Thorax 67:957–963
28. Tomalak W, Antczak A, Boros P, Czajkowska-Malinowska M, Franczuk M, Gondorowicz K, Krzywiecki A, Radliński J, Siergiejko Z, Śliwinśki P, Wesołowski S, Ziora D (2006) Spirometry guidelines of the Polish society of lung diseases. Pneumonol Alergol Pol 74(Suppl 1):2–31
29. Troosters T, van der Molen T, Polkey M, Rabinovich RA, Vogiatzis I, Weisman I, Kulich K (2013) Improving physical activity in COPD: towards a new paradigm. Respir Res 14:115–122
30. Wedzicha JA, Donaldson GC (2003) Exacerbations of chronic obstructive pulmonary disease. Respir Care 48:1204–1213